High dose chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary lymph nodes.

Shiba, E; Akazawa, K; Kim, S J; Taguchi, T; Tsukamoto, F; Ogawa, H; Furukawa, J; Yamamoto, H; Noguchi, S

Shiba, E; Akazawa, K; Kim, S J; Taguchi, T; Tsukamoto, F; Ogawa, H; Furukawa, J; Yamamoto, H; Noguchi, S.

Affiliation

Shiba E; Department of Breast and Endocrine Surgery, Osaka Kosei-Nenkin Hospital, 4-2-78 Fukushima, Fukushima-ku, Osaka 553-0003, Japan.

Breast Cancer ; 7(4): 302-6, 2000.

Article in En | MEDLINE | ID: mdl-11114854

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Adult; Axilla; Breast Neoplasms/mortality; Disease-Free Survival; Female; Humans; Lymphatic Metastasis; Middle Aged; Prospective Studies

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: Breast Cancer Journal subject: NEOPLASIAS Year: 2000 Document type: Article Affiliation country: Japan Country of publication: Japan

Search on Google

Add to My VHL

XML

PubMed Links